SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors pending FDA decision on deramiocel for Duchenne muscular dystrophy is driving attention, with traders focused on the Nov. 22 PDUFA date, the amended upper-limb data and new commercial-launch job postings they interpret as possible signs of readiness. Approval hopes and short-squeeze speculation are prominent, while skeptics note that hiring does not confirm an FDA outcome and cite the companys prior regulatory setback and remaining efficacy questions.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCaths Medicare add-on reimbursement could decline after the first quarter of 2027 has raised concerns about pricing and revenue for CorMedixs flagship product, amid a sharp selloff. Traders are split between viewing the comments as a serious commercial risk and arguing they are preliminary and at odds with CMS estimates; many also criticize managements silence, while some are buying the dip.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios accelerated FDA approval of a treatment for recurrent respiratory papillomatosis has renewed focus on competition with Precigens PAPZIMEOS, which is already approved for the same disease. Traders are divided over how much market share the new entrant could threaten, with some calling the selloff an overreaction and pointing to Precigens head start and different approval status.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX is drawing attention for its breakout ahead of the expected Q3 earnings report, with traders focused on BRIUMVIs growth and possible further upside. Buyout and short-squeeze chatter is prominent but speculative; some traders instead attribute the move to earnings expectations and the companys commercial momentum.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS REGAL Phase 3 leukemia trial reached its prespecified event threshold, triggering final analysis and putting the GPS survival readout in focus. Traders are sharply divided over whether GPS will show a benefit or whether control-arm outcomes and trial assumptions could undermine the bull case, amid volatile trading and speculation about short positioning.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A steep tech-led selloff has focused discussion on fears that heavy AI infrastructure spending may not produce adequate returns, alongside concerns about persistent inflation and higher interest rates. Traders are divided on whether the drop marks an oversold buying opportunity or signals further losses, with debate also citing weak tech outlooks and volatile trading.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

Silvers sharp selloff, amid inflation concerns and expectations of higher interest rates, is driving attention to SLV. Traders are split between calling the decline an oversold buying opportunity and warning that selling may continue, with some blaming market manipulation without evidence.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons strong third-quarter earnings, fueled by Eylea HD sales and higher Sanofi collaboration revenue from Dupixent, drove a sharp share-price jump and breakout discussion. Traders largely welcomed the results, while some debated whether newer drugs can sustain growth; the upcoming cemdisiran decision also drew attention.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins steep selloff ahead of its earnings report is driving discussion, with traders citing analyst price-target cuts and worries about growth, competition, and weakness in the broader ad market. Some expect those concerns to weigh on results, while others argue the decline is disconnected from the companys profitability and see the report as a potential sentiment test.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 76,874.98691422 USD and is down -4.82 over the last 24 hours. It is currently trading on 12773 active market(s) with $58,826,736,014.03 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

A reported major Binance security breach and temporary withdrawal disruption have intensified selling in Bitcoin and other crypto assets, amid concerns about exchange security and possible contagion. Traders disagree over whether the incident undermines confidence in Bitcoin or is an exchange-specific problem, with bearish calls and panic-selling set against dip-buying and claims that Bitcoin is holding up relatively well.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

95-Year-Old Wall Street Law Firm Weil Gotshal Suddenly Lurches Towards Shutdown

95-Year-Old Wall Street Law Firm Weil Gotshal Suddenly Lurches Towards Shutdown

 Authored by Bill Pan via The Epoch Times,Weil, Gotshal & Manges is poised to close after a wave of senior partner departures and failed merger talks, bringing a potential end to a Wall Street law firm known...

APi (APG) Tops Q3 Earnings and Revenue Estimates

APi (APG) delivered earnings and revenue surprises of +6.38% and +6.90%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

AMN vs. TRI: Which Stock Is the Better Value Option?

Thomson Reuters Launches AI for Tax and Audit That Knows the Answer, and Why It's Right

Thomson Reuters Launches AI for Tax and Audit That Knows the Answer, and Why It's Right Thomson Reuters Launches AI for Tax and Audit That Knows the Answer, and Why It's RightPR NewswireTORONTO, Oct. 22, 2026 The next generation of CoCounsel Tax, Audit & Accounting plans the work, applies the...

Thomson Reuters Provides Supplemental Financial Information Following Close of Global Print Transaction

Thomson Reuters Provides Supplemental Financial Information Following Close of Global Print Transaction Thomson Reuters Provides Supplemental Financial Information Following Close of Global Print TransactionPR NewswireTORONTO, Oct. 19, 2026 TORONTO, Oct. 19, 2026 /PRNewswire/ -- As previously...

Thomson Reuters' AI Push Gains Steam: Is TRI Poised for Growth?

TRI is advancing AI products, raising its 2026 growth outlook and selling a majority stake in Global Print to sharpen its strategic focus.

Intuit's Lower DIY Tax Pricing: Will It Weigh on Revenue Growth?

INTU revamps its DIY tax strategy with lower-cost Credit Karma Tax options to win back customers, even as pricing shifts threaten to slow TurboTax growth in fiscal 2027.

Legal Work Crosses Borders. Now So Does CoCounsel Legal.

Legal Work Crosses Borders. Now So Does CoCounsel Legal. Legal Work Crosses Borders. Now So Does CoCounsel Legal.PR NewswireTORONTO, Oct. 14, 2026Thomson Reuters launches the next generation of CoCounsel Legal globally, adding cross-border legal research from more than 100 countries and territories...

Why Thomson Reuters Stock Topped the Market on Thursday

Key PointsThe company finalized the divestment of a majority stake in its printing unit...

Can 10% Core Growth Keep Thomson Reuters' Momentum Intact?

TRI's Big 3 businesses deliver 10% organic growth, reinforcing their role in driving revenues as recurring sales expand.

Thomson Reuters Corp. engages in the provision of news and information for professional markets. It operates through the following segments: Legal Professionals, Corporates, Tax and Accounting Professionals, Reuters News, and Global Print. The Legal Professionals segment provides research and workflow products to law firms and government. The Corporates segment serves corporate customers with full suite of content-enabled technology solutions for in-house legal, tax, regulatory, compliance, and information technology professionals. The Tax and Accounting Professionals segment offers research and workflow products focusing on intuitive tax offerings and automating tax workflows to tax, accounting, and audit professional in accounting firms. The Reuters News segment supplies business, financial, national, and international news to professionals via desktop terminals. The Global Print segment offers legal and tax information primarily in print format to customers around the world. The company was founded in 1799 and is headquartered in Toronto, Canada.

Thomson-Reuters Corp

Why DOCU, TRI Stocks Slid Over 3% After Google Cloud’s Latest AI Release

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>Thomson Reuters and DocuSign shares fell 4% and 3.2%, respectively, amid fears of AI disruption.</li><li>Anthropic’s legal AI launch in February triggered an 18% plunge in Thomson Reuters shares.</li><li>Google’s latest move is another test for the SaaS sector, even as software stocks have staged periods of recovery this month.</li></ul>Alphabet, Inc.-owned Google’s latest artificial-intelligence&nbsp;unveiling is giving investors another reason to worry about the threat AI poses to traditional software, with shares of Thomson Reuters and DocuSign falling Tuesday.Google Cloud CEO Thomas Kurian announced Gemini Enterprise for Legal, a version of Google’s enterprise AI platform designed for law firms and corporate legal teams.&nbsp;The offering can connect with legal data and workflow systems and use AI agents for tasks including research, document analysis and contract-related work. Google also launched a parallel Gemini Enterprise offering for financial services.&nbsp;&nbsp;<h2 class="st-heading-2">Thomson Reuters, DocuSign Hit&nbsp;</h2>Shares of Thomson Reuters Corp., which has a sizable legal services business through its properties Westlaw, Practical Law, and CoCounsel, fell 4% on Tuesday. Shares of DocuSign, which provides software for electronic signatures and managing digital agreements and contracts, dropped 3.2%.The moves underscore a broader concern that has repeatedly hit software stocks this year: AI companies are moving from offering general-purpose chatbots to&nbsp;taking on specific, high-value software workflows.Thomson Reuters launched Thomson 1.0, its own open-weight legal-focused large language model, just a day earlier. Google lists DocuSign among the connectors that can be integrated into Gemini Enterprise for Legal, highlighting how AI platforms could increasingly sit on top of — rather than simply replace — existing software workflows.&nbsp;&nbsp;Anthropic’s launch of legal-focused AI tools in February triggered a much sharper selloff across legal and information-services stocks. Thomson Reuters plunged as much as 18% at the time.<h2 class="st-heading-2">Saas Stocks Rebound, But AI Fears Remain</h2>That makes Google’s latest move another test for the SaaS sector, even as software stocks have staged a recovery this month. Investors are increasingly separating AI beneficiaries from companies whose core products could be automated or bundled into AI platforms.The result is a widening gap between SaaS winners and losers as Wall Street reassesses which software businesses have durable competitive moats.In August, Paycom Software and Palantir Technologies returned over 40%, emerging as top software gainers in the S&amp;P 500. Trade Desk and AppLovin Corp are the biggest losers, with 27% and 22% drops respectively.<a href="https://stocktwits.com/symbol/IGV">The iShares Expanded Tech-Software Sector ETF (IGV)</a>, seen as a benchmark for the software sector, rose 7.7% so far in August but remains 3.6% lower for the year.On Stocktwits, the retail sentiment was ‘neutral’ for TRI and DOCU and ‘extremely bearish’ for GOOGL and IGV on Tuesday.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/intuit-ceo-admits-pricing-is-driving-turbo-tax-customers-away-says-low-cost-fix-coming-as-stock-extends-tumble-overnight/cZYNiVQRJoq">Intuit CEO Admits Pricing Is Driving TurboTax Customers Away, Says Low-Cost Fix Coming As Stock Extends Tumble Overnight</a>&nbsp;

Businessman working on laptop with artificial intelligence law icons showing regulation, ethics and compliance standard. (Source: Getty Images)

Google launched Gemini Enterprise for Legal, targeting research, document analysis, and contract work.

DocuSign Inc

Alphabet Inc - Ordinary Shares - Class C

Alphabet Inc Class A

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

$TRI up +28% in 1M but still down -25% for 1Y. It's waking up. People thought AI would hurt them and it sold off but they're the ones with the data! And now people are starting to understand how important data is to AI. It's why $INOD has 10,000 employees.

Uncle Steven

$TRI: a hurdle looms in Johnston. An earlier Michigan SSN display case was dismissed for not pleading actual harm, and Thomson Reuters disputes the 5-digit CLEAR and Westlaw claims. Nothing to claim. Open Class Actions.

Clam Clamwell

$TRI: Johnston is led by Bursor & Fisher and The Miller Law Firm in E.D. Mich., 2:26-cv-11432. One Michigan SSN Privacy Act count over alleged CLEAR and Westlaw displays. Still complaint stage, nothing to claim. Open Class Actions.

$TRI: note the defendant in Johnston is Thomson Reuters America Corp, not the parent company. It says it places a high priority on privacy and strongly disputes the alleged 5-digit SSN displays. Nothing to claim. Open Class Actions.

$TRI I guess I wasn't too early! AI doing lawyers' work for them. And accountants. Stealth agentic / data play. Value is still tremenous. Less than 1000 followers.

Feed

News

Sentiment

Earnings

Fundamentals

Info

TRI Thomson-Reuters Corp

Fundamentals

Latest TRI News